Form 4: Omnicell Director Receives Restricted Stock Grant

Eileen J. Voynick, a Director at Omnicell, Inc., was granted 4,785 restricted shares under the company's equity incentive plan.

Summary

• Eileen J. Voynick, a Director of Omnicell, Inc., received a grant of 4,785 restricted shares on June 1, 2026.
• This grant is part of the Issuer's equity incentive plan and is in consideration for services as a Board Member.
• The restricted shares are expected to vest in full on the one-year anniversary of the grant date.
• Following this transaction, Voynick beneficially owns 20,011 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard compensation grant to a director rather than a significant strategic or financial development.

Positives

• Director compensation through equity grants aligns management and board interests with shareholders.
• The grant of restricted stock indicates continued commitment and incentive for the director.
• The shares are granted under an existing equity incentive plan, suggesting a structured compensation approach.

Negatives

• No specific financial performance metrics are tied to this grant in the provided information.
• The value of the grant is not explicitly stated, only the number of shares.

Risks

• The value of the restricted stock is subject to market fluctuations and the future performance of Omnicell.
• Vesting conditions, while standard, mean the shares are not immediately available to the director.

Future Outlook

The restricted shares granted to Eileen J. Voynick will vest in full on the one-year anniversary of the grant date, June 1, 2027.

Industry Context

StockSavvy.ai notes that grants of restricted stock to directors are a common practice in the technology and healthcare sectors, including companies like Omnicell, to attract and retain talent and align incentives with long-term company performance.

Stakeholder Impact

• Shareholders: The grant aligns director incentives with long-term company performance, potentially benefiting shareholders if the stock price appreciates.
• Employees: This filing is primarily relevant to executive and director compensation structures, with indirect implications for overall company governance.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• The restricted shares will vest on June 1, 2027.
• Eileen J. Voynick will continue to serve as a Director of Omnicell, Inc.

Key Dates

Keywords

Omnicell, OMCL, Form 4, Insider Trading, Restricted Stock, Equity Incentive Plan, Director Compensation, Beneficial Ownership, Securities Exchange Act